Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.680
+0.160 (10.53%)
Jun 6, 2025, 2:44 PM - Market open
MRKR's stock price has decreased by -53.68% in the past year and price targets may not have had time to catch up.
Marker Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$13.17
Upside
+683.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| WBB Securities | WBB Securities | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +644.05% | Apr 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +376.19% | Mar 5, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $11 → $19 | Strong Buy | Maintains | $11 → $19 | +1,030.95% | Oct 21, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +554.76% | Apr 30, 2024 |
| Roth Capital | Roth Capital | Strong Buy → Hold Downgrades $30 → $10 | Strong Buy → Hold | Downgrades | $30 → $10 | +495.24% | Feb 17, 2022 |
| Piper Sandler | Piper Sandler | Buy Initiates $60 | Buy | Initiates | $60 | +3,471.43% | Mar 25, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +3,471.43% | Mar 19, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +3,471.43% | Mar 18, 2021 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $50 → $25 | Buy → Hold | Downgrades | $50 → $25 | +1,388.10% | May 12, 2020 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $60 | Buy | Maintains | $100 → $60 | +3,471.43% | Nov 13, 2019 |
| Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +5,852.38% | May 30, 2019 |